Safety Considerations with Pharmacological Treatment of Gestational Diabetes Mellitus
Drug Safety | ADIS INT LTD | Published : 2015
No sources of funding were used to assist in the preparation of this review. David Simmons has received consulting fees from Novo Nordisk and travel support from Novo Nordisk, Sanofi and Eli Lilly. He has no other conflicts of interest that are directly relevant to the content of this review.